87710789 - C COMPREHENSIVE CELL SOLUTIONS

Information

• Trademark
• 87710789

• Source

• Serial Number

  87710789

• Registration Number

  5573697

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 39 - Transport
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  December 06, 2017
  7 years ago

• Registration Date

  October 02, 2018
  6 years ago

• Transaction Date

  December 10, 2024
  2 months ago

• Status Date

  October 02, 2018
  6 years ago

• Published for Opposition Date

  July 17, 2018
  6 years ago

• Location Date

  October 02, 2018
  6 years ago

• First Use Anywhere Date

  January 23, 2017
  8 years ago

• First Use In Commerce Date

  January 23, 2017
  8 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MICKLEBURGH, LINDA

• Attorney Docket Number

  584340076001

  Attorney Name

  CYNTHIA JOHNSON WALDEN

  Law Office Assigned Location Code

  L60

• Owners

  • New York Blood Center, Inc.

Case File Statements

• GS0401: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, cryopreservation of human cells
• DM0000: The mark consists of the terms "COMPREHENSIVE CELL SOLUTIONS" in dark blue text with gray shadowing, positioned to the right of a stylized letter "C". The stylized letter "C" is divided into four segments, changing from light blue to dark blue from top to bottom. Solid bubbles surround the "C" also in the same light blue and dark blue radiating from each segment.
• GS0391: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, storage of blood and stem cells
• GS0051: Products to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products for medical and clinical trial use, antibody positive plasma, phenotyped red cell units, monoclonal antibodies to RBC antigens, cord blood; mononuclear cells, progenitor cells, antibody preparations for use in medical clinical trials, research and medical purposes
• CC0000: The color(s) light blue, dark blue and gray is/are claimed as a feature of the mark.
• GS0351: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, providing independent review of clinical trials for business purposes
• GS0441: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, tissue bank services; cell processing services for use by others; stem cell storage; collection and preservation of human blood, apheresis, red blood cells, plasma and bone marrow
• DS0000: "COMPREHENSIVE CELL SOLUTIONS"
• GS0421: Services to support and manage transfusion medicine, regenerative medicine and cellular-therapy related research and clinical programs from discovery through development and to the clinic, namely, medical laboratory, pharmaceutical research services and pharmaceutical clinical trials for others

Case File Event Statements

• 12/9/2017 - 7 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 12/17/2017 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/19/2017 - 7 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 3/13/2018 - 6 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 3/15/2018 - 6 years ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 3/20/2018 - 6 years ago

  7 - PRIORITY ACTION WRITTEN Type: CPRA

• 3/20/2018 - 6 years ago

  8 - PRIORITY ACTION E-MAILED Type: GPRA

• 3/20/2018 - 6 years ago

  9 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 5/29/2018 - 6 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 6/4/2018 - 6 years ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 6/27/2018 - 6 years ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/17/2018 - 6 years ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 7/17/2018 - 6 years ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/2/2018 - 6 years ago

  17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 10/2/2023 - a year ago

  18 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 12/6/2024 - 2 months ago

  19 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 12/6/2024 - 2 months ago

  22 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/6/2024 - 2 months ago

  21 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 12/6/2024 - 2 months ago

  20 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 12/6/2024 - 2 months ago

  23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 5/29/2018 - 6 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/15/2018 - 6 years ago

  6 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 5/29/2018 - 6 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA